KEGG   DRUG: D02967Help
Entry
D02967                      Drug                                   

Name
Apolizumab (USAN/INN)
Activity
Anti-cancer agent against 1D10 antigen positive B-cell malignancies
Comment
Monoclonal antibody
Target
HLA-DR beta [HSA:3123 3125 3126 3127] [KO:K06752]
  Pathway
hsa04514  Cell adhesion molecules (CAMs)
hsa04612  Antigen processing and presentation  
 
Brite
Target-based classification of drugs [BR:br08310]
 Others
  Cellular antigens
   HLA-DR beta
    Apolizumab
     D02967  Apolizumab (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 
267227-08-7
PubChem: 
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system